The Cardiovascular Literature-Based Risk Algorithm (CALIBRA): Predicting Cardiovascular Events in Patients With

Luca Neri1, Caterina Lonati2, Jasmine Ion Titapiccolo1

  • 1Clinical and Data Intelligence Systems-Advanced Analytics, Fresenius Medical Care Deutschland GmbH, Vaiano Cremasco, Italy.

Frontiers in Nephrology
|September 7, 2023
PubMed

Insights

The new CArdiovascular, LIterature-Based, Risk Algorithm (CALIBRA) accurately predicts cardiovascular risk in chronic kidney disease (CKD) patients. CALIBRA outperforms existing models, offering improved risk stratification for better clinical management.

Area of Science:

  • Nephrology
  • Cardiology
  • Biostatistics

Background:

  • Cardiovascular disease (CVD) is the leading cause of mortality in chronic kidney disease (CKD) patients.
  • Current risk prediction models are often inadequate for this population.
  • Accurate CVD risk assessment is crucial for effective clinical management of CKD.

Purpose of the Study:

  • To develop and validate a novel, literature-based risk prediction model for cardiovascular (CV) hospitalizations in CKD patients.
  • To assess the performance of the new model, named CArdiovascular, LIterature-Based, Risk Algorithm (CALIBRA), against existing CV risk scores.

Main Methods:

  • A literature-based, naïve-bayes model (CALIBRA) was developed incorporating 31 traditional and CKD-specific risk factors.
  • CALIBRA was validated in two independent CKD cohorts: the FMC NephroCare (EuCliD®) and the German Chronic Kidney Disease (GCKD) study.
  • Model performance was evaluated using c-statistics and calibration, with comparisons to Framingham Heart Study (FHS), ASCVD, and INDANA risk scores.

Main Results:

  • CALIBRA demonstrated good discrimination in both validation cohorts (AUC 0.79 in EuCliD®, 0.73 in GCKD).
  • CALIBRA showed significantly improved accuracy over FHS, ASCVD, and INDANA in both cohorts (ΔAUC ranging from -0.04 to -0.22).
  • The model maintained accuracy even with missing data, indicating robustness in real-world settings.

Conclusions:

  • CALIBRA offers accurate and robust cardiovascular risk stratification for CKD patients.
  • The model provides superior predictive accuracy compared to established CV risk scores.
  • CALIBRA's generalizability across diverse CKD populations and clinical settings is supported by the findings.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
33
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
41
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
24
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
29
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
26